DYRK1A and Alzheimer disease: Accordingly, DYRK1A inhibition suppresses astrocyte reactivity and rescues cognitive deficits in AD mouse models (Ceyzériat et al., 2018; Gong et al., 2019; Lee et al., 2020; Melchior et al., 2019; Souchet et al., 2019).